Tenaya Therapeutics, Inc. (TNYA)
NASDAQ: TNYA · Real-Time Price · USD
0.8587
-0.0363 (-4.06%)
At close: Mar 11, 2026, 4:00 PM EDT
0.8400
-0.0187 (-2.18%)
After-hours: Mar 11, 2026, 7:56 PM EDT

Tenaya Therapeutics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
186118124221134782
Market Cap Growth
127.84%-4.27%-44.10%64.75%-82.83%-
Enterprise Value
141.13118.4773.14124.85-41.05544.88
Last Close Price
0.860.711.433.242.0118.95
PE Ratio
--1.21-1.09-1.93-0.73-4.62
PB Ratio
1.77-1.331.590.552.81
P/TBV Ratio
--1.311.720.371.21
P/FCF Ratio
---1.35-2.14-1.07-9.11
P/OCF Ratio
---1.37-2.17-1.29-12.87
EV/EBITDA Ratio
--1.27-0.68-1.020.34-7.80
EV/EBIT Ratio
--1.27-0.63-0.950.33-7.48
EV/FCF Ratio
---0.80-1.210.33-6.34
Debt / Equity Ratio
--0.120.060.050.05
Debt / EBITDA Ratio
---0.13-0.10-0.13-0.22
Debt / FCF Ratio
---0.15-0.12-0.12-0.18
Net Debt / Equity Ratio
---0.51-0.66-0.70-0.85
Net Debt / EBITDA Ratio
--0.450.751.443.37
Net Debt / FCF Ratio
--0.520.891.372.74
Quick Ratio
--3.854.607.6911.54
Current Ratio
--4.224.917.9911.73
Return on Equity (ROE)
-195.14%-195.14%-95.69%-64.83%-47.39%-34.80%
Return on Assets (ROA)
-155.63%-155.63%-79.84%-58.38%-42.36%-31.49%
Return on Invested Capital (ROIC)
-412.08%-412.08%-250.01%-219.32%-217.93%-248.67%
Return on Capital Employed (ROCE)
-179.54%-179.54%-92.11%-65.19%-45.92%-33.43%
Earnings Yield
-50.70%-82.92%-91.61%-51.85%-137.31%-21.64%
FCF Yield
-39.52%0.00%-73.96%-46.66%-93.06%-10.98%
Buyback Yield / Dilution
-0.00%-38.58%-2.06%-57.87%-24.14%
Updated Dec 31, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q